MY ACCOUNT

ABOUT

SECTIONS

unbolded

Citigroup is losing another top foreign-exchange banker, with Jeff Feig leaving the firm

Event-driven duo exit Cheyne Capital Management

Co-manager Michel Massoud has left the $7bn alternatives firm, with head of event-driven investments set to retire as recent recruit from Meditor takes over the team

Growth in investment banking and equities trading lead the securities firm's growth

The bourse will work with Bank of China and Agriculture Bank of China to establish new renminbi products and clearing processes

The Deutsche Börse-owned derivatives exchange is introducing a new range of incentives to encourage trading in Euribor interest rate products

Covidien deal cements Goldman Sachs' lead in healthcare

The US bank is firmly ahead of its rivals in the healthcare advisory league table as we approach the half-way point of the year

Technical glitch hits trading on NYSE Liffe

Trading in Euribor and Eonia futures grinds to a halt on Tuesday

BAML does double over UBS in Extel rankings

The bank has retained top spot in the annual battle over which broker provides the best research on European companies

Deal is Apax's seventh US sale in the last 12 months at an active time for private equity exits

China closer to relaxing foreign investment rules

The Chinese Securities Regulatory Commission is considering relaxing the rules which restrict foreign investment in Chinese mutual funds

Ex-CVC managing director becomes partner at May Capital and joins the management of a pub group backed by the firm

IEX Group hires former top SEC official to help with exchange push

The upstart trading venue brings in former regulator to help with its efforts to transform into a stock exchange

https://assets.fnlondon.com/2014/06/4073573372.jpg

The second Financial News London to Monte Carlo bike ride is currently underway. Starting in London last Saturday, and ending at The Fund Forum International 2014 conference the following Sunday, the cycle ride covers over 1,000 miles over nine days.

Allergan's bitter pill for Morgan Stanley

Allergan, which is fending off a $53 billion takeover bid by Valeant, released emails sent by senior Morgan Stanley bankers appearing to denigrate Valeant and its business strategy

https://www.wsj.com/?type=allesseh_content_full_list

Citigroup currencies chief to leave bank

Event-driven duo exit Cheyne Capital Management

Jefferies profit rises 55%

LSE joins forces with Chinese banks

Eurex seeks Euribor liquidity boost

Covidien deal cements Goldman Sachs' lead in healthcare

Technical glitch hits trading on NYSE Liffe

BAML does double over UBS in Extel rankings

Apax strikes third US deal of the month

China closer to relaxing foreign investment rules

Former CVC exec joins Bulkin's firm

IEX Group hires former top SEC official to help with exchange push

London to Monte Carlo 2014

Allergan's bitter pill for Morgan Stanley